Materias dentro de su búsqueda.
Mostrando 4,601 - 4,620 Resultados de 4,918 Para Buscar '"Pfizer"', tiempo de consulta: 4.53s Limitar resultados
  1. 4601
    “…DISCLOSURES: Octavio Ramilo, MD, Bill & Melinda Gates Foundation (Grant/Research Support)Janssen (Grant/Research Support, Advisor or Review Panel member)Medimmune (Grant/Research Support)Merck (Advisor or Review Panel member)NIH/NIAID (Grant/Research Support)Pfizer (Consultant, Advisor or Review Panel member)Sanofi/Medimmune (Consultant, Advisor or Review Panel member) Asuncion Mejias, MD, PhD, MsCS, Janssen (Grant/Research Support, Advisor or Review Panel member)Merck (Advisor or Review Panel member)Roche (Advisor or Review Panel member)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1465. Age-Dependent Interactions Among Clinical Characteristics, Viral Loads and Disease Severity in Young Children with Respiratory Syncytial Virus Infection (RSV) Infection
  2. 4602
    “…DISCLOSURES: Claudia R. Libertin, MD, Pfizer, Inc. (Grant/Research Support, Research Grant or Support)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    317. Case Series of Echinococcus Infections at Mayo Clinic Florida
  3. 4603
    “…Langley, MD, GSK group of companies (Research Grant or Support)Immunivaccines Inc (Scientific Research Study Investigator, Research Grant or Support)Janssen (Research Grant or Support)Pfizer (Research Grant or Support)Symvivo (Scientific Research Study Investigator, Research Grant or Support)VBI Vaccines (Research Grant or Support) Nathalie Machluf, PhD, VBI Vaccines Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1051. Rapid onset of seroprotection rates in young adults immunized with a tri-antigenic hepatitis B virus (HBV) vaccine compared to a mono-antigenic HBV vaccine
  4. 4604
    “…(Consultant)Medimmune (Consultant, Research Grant or Support)Merck (Consultant, Research Grant or Support)NIH (Grant/Research Support)Novadigm (Consultant)Novartis (Consultant, Research Grant or Support)Pfizer (Grant/Research Support)Regeneron (Consultant, Research Grant or Support)Tetraphase (Consultant)Theravance (Consultant, Research Grant or Support)Trius (Consultant)xBiotech (Consultant)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    708. Infective Endocarditis Complicating Delivery in Pregnancy: Risk Factors, Complications, and Delivery Outcomes
  5. 4605
    “…Grijalva, MD, MPH, AHRQ (Grant/Research Support)Campbell Alliance (Grant/Research Support)CDC (Grant/Research Support)FDA (Grant/Research Support)Merck (Consultant)NIH (Scientific Research Study Investigator)Pfizer (Consultant)Sanofi (Consultant)Sanofi (Grant/Research Support) Natasha B. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    432. High concordance between self-collected nasal swabs and saliva samples for detection of SARS-CoV-2
  6. 4606
    “…(Research Grant or Support)Paratek Pharma, LLC (Research Grant or Support)Pfizer (Research Grant or Support)Qpex Biopharma (Research Grant or Support) Leah Woosley, n/a, Merck & Co, Inc. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1169. In Vitro Activity of Posaconazole versus Voriconazole for the Treatment of Invasive Aspergillosis in Adults Enrolled in a Clinical Trial
  7. 4607
    “…(Research Grant or Support)Merck (Research Grant or Support)Merck (Research Grant or Support)Pfizer (Research Grant or Support)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    1695. Tebipenem: An Oral Carbapenem with activity against Multi-drug Resistant Urinary Tract Infection isolates of Escherichia coli collected from US Medical Centers during 2019
  8. 4608
    “…(Consultant)Medimmune (Consultant, Research Grant or Support)Merck (Consultant, Research Grant or Support)NIH (Grant/Research Support)Novadigm (Consultant)Novartis (Consultant, Research Grant or Support)Pfizer (Grant/Research Support)Regeneron (Consultant, Research Grant or Support)Tetraphase (Consultant)Theravance (Consultant, Research Grant or Support)Trius (Consultant)xBiotech (Consultant)…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    189. Risk Factors and Outcomes of Hematogenous Vertebral Osteomyelitis in Patients with staphylococcus Aureus Bacteremia: Results from a 20-year Prospective Cohort
  9. 4609
    “…Overall, immunosuppressants do not seem to be deleterious in this scenario, and the control of inflammatory activity seems to be key when facing the pandemic. FUNDING: Pfizer, Sanofi, Amgen, Galapagos, and Lilly.…”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    SARS-CoV-2 outbreak in immune-mediated inflammatory diseases: the Euro-COVIMID multicentre cross-sectional study
  10. 4610
    “…The SARS-CoV-2 spike mRNA vaccine (named BNT162b2/Pfizer), authorized by the FDA, has shown high efficacy in preventing SARS-CoV-2 infection after administration of two doses in individuals 16 years of age and older. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Vaccination strategy and anti - SARS-CoV-2 S titers in healthcare workers of the INT – IRCCS “Fondazione Pascale” Cancer Center (Naples, Italy)
  11. 4611
    “…METHODS: In a multicenter observational pilot study, 2 weeks after a first vaccination (BNT162b2/Pfizer-BioNTech [Comirnaty] or ChAdOx1 nCoV-19/Oxford-Astra-Zeneca [Vaxzevria]), hemodialysis patients (N = 23), peritoneal dialysis patients (N = 4) and healthy staff (N = 14) were tested for SARS-CoV-2-spike IgG/IgM, Nucleocapsid-protein-IgG-antibodies and plasma ACE2-receptor-binding-inhibition capacity. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immunogenicity of a first dose of mRNA- or vector-based SARS-CoV-2 vaccination in dialysis patients: a multicenter prospective observational pilot study
  12. 4612
    por Thompson, Mark G., Burgess, Jefferey L., Naleway, Allison L., Tyner, Harmony, Yoon, Sarang K., Meece, Jennifer, Olsho, Lauren E.W., Caban-Martinez, Alberto J., Fowlkes, Ashley L., Lutrick, Karen, Groom, Holly C., Dunnigan, Kayan, Odean, Marilyn J., Hegmann, Kurt, Stefanski, Elisha, Edwards, Laura J., Schaefer-Solle, Natasha, Grant, Lauren, Ellingson, Katherine, Kuntz, Jennifer L., Zunie, Tnelda, Thiese, Matthew S., Ivacic, Lynn, Wesley, Meredith G., Mayo Lamberte, Julie, Sun, Xiaoxiao, Smith, Michael E., Phillips, Andrew L., Groover, Kimberly D., Yoo, Young M., Gerald, Joseph, Brown, Rachel T., Herring, Meghan K., Joseph, Gregory, Beitel, Shawn, Morrill, Tyler C., Mak, Josephine, Rivers, Patrick, Poe, Brandon P., Lynch, Brian, Zhou, Yingtao, Zhang, Jing, Kelleher, Anna, Li, Yan, Dickerson, Monica, Hanson, Erika, Guenther, Kyley, Tong, Suxiang, Bateman, Allen, Reisdorf, Erik, Barnes, John, Azziz-Baumgartner, Eduardo, Hunt, Danielle R., Arvay, Melissa L., Kutty, Preeta, Fry, Alicia M., Gaglani, Manjusha
    Publicado 2021
    “…BACKGROUND: Information is limited regarding the effectiveness of the two-dose messenger RNA (mRNA) vaccines BNT162b2 (Pfizer–BioNTech) and mRNA-1273 (Moderna) in preventing infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and in attenuating coronavirus disease 2019 (Covid-19) when administered in real-world conditions. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Prevention and Attenuation of Covid-19 with the BNT162b2 and mRNA-1273 Vaccines
  13. 4613
    por Fatkhullin, Ramil, Shuvaev, Vasily
    Publicado 2020
    “…DISCLOSURES: Shuvaev:Novartis:Honoraria, Speakers Bureau;BMS:Honoraria, Speakers Bureau;Pfizer:Honoraria, Speakers Bureau.…”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immune Thrombocytopenia Associated with COVID-19 - Case Series
  14. 4614
    “…In this study we aimed to assess the antibody and cellular responses of older people after a single dose of either the BNT162b2 vaccine (tozinameran; Pfizer–BioNTech) or ChAdOx1 nCoV-19 vaccine (Oxford University–AstraZeneca). …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Immunogenicity of single vaccination with BNT162b2 or ChAdOx1 nCoV-19 at 5–6 weeks post vaccine in participants aged 80 years or older: an exploratory analysis
  15. 4615
    “…DESCRIPTION: Étude observationnelle monocentrique portant sur l’ensemble des patients HDC du centre à qui la vaccination contre la COVID-19 (vaccin ARNm BNT162b2 [Pfizer–BioNTech®]) a été proposée. Trois injections ont été proposées, les deux premières réalisées à 28 jours d’intervalle et la troisième dès l’entrée en vigueur des nouvelles recommandations pour les patients hémodialysés. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Réponse à la vaccination contre le SARS-CoV-2 chez des patients hémodialysés chroniques
  16. 4616
    “…DESCRIPTION CLAIRE ET COMPLÈTE DE L’EXPÉRIENCE: Nous avons évalué la réponse à court terme d’un Vaccin anti-covid-19 à base d’ARN messenger (BNT162b2 mRNA COVID-19, Pfizer-BioNTech), chez 252 patients hémodialysés (HD), avec ou sans immunité documentée préexistante anti SARS-Cov2. …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Réponse immunologique au vaccin à ARNm anti-COVID-19 chez les patients dialysés chroniques
  17. 4617
    “…Patients included in the SHCS or the STCS will be eligible for randomization to either receiving the mRNA vaccine Comirnaty® (Pfizer/BioNTech) or the COVID-19 mRNA Vaccine Moderna®. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    A trial platform to assess approved SARS-CoV-2 vaccines in immunocompromised patients: first sub-protocol for a pilot trial comparing the mRNA vaccines Comirnaty® and COVID-19 mRNA Vaccine Moderna®
  18. 4618
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Real‐World Clinical and Economic Outcomes in Selected Immune‐Related Adverse Events Among Patients with Cancer Receiving Immune Checkpoint Inhibitors
  19. 4619
    “…Our previously published cohort study showed that methotrexate, but not targeted biologics, impaired functional humoral immunity to a single dose of COVID-19 vaccine BNT162b2 (Pfizer-BioNTech), whereas cellular responses were similar. …”
    Enlace del recurso
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
  20. 4620
    “…METHODS: Patients were vaccinated with BNT162b2 mRNA (Pfizer/BioNTech), mRNA-1273 (Moderna), or JNJ-78436735 (Johnson & Johnson). …”
    Enlace del recurso
    Enlace del recurso
    Online Artículo Texto
    OAB-045: COVID-19 vaccine responsiveness in patients with Multiple Myeloma and Waldenström Macroglobulinemia
Herramientas de búsqueda: RSS